Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN · BSE: 531633 · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹591.00
Market cap: ₹1,184 Cr
Revenue (annual): ₹671.0 Cr
Net profit (annual): ₹87.89 Cr
P/E (TTM): 12.3×Sector 50.4×
Promoter holding: 49.78%+0.00% QoQ
FII holding: 4.60%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Other Announcement 1 Management Change 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

13 Aug 2026 11:37 IST BSE

Financial Results

Lincoln Pharmaceuticals Q1 FY27 Results: Net Profit ₹36.2 Cr, Up 30.7% YoY

Lincoln Pharmaceuticals Ltd reported revenue from operations of ₹177.3 Cr (+15.1% YoY) and net profit of ₹36.2 Cr (+30.7% YoY) for Q1 FY27.

Key figure: Net profit ₹36.2 Cr · +30.7% YoY

Open full results → Read the filing ↗

28 May 2026 17:09 IST BSE

Financial Results

Lincoln Pharmaceuticals Q4 FY26 Results: Net Profit ₹11.6 Cr, Up 0.0% YoY

Lincoln Pharmaceuticals Ltd reported revenue from operations of ₹187.3 Cr (+11.4% YoY) and net profit of ₹11.6 Cr (+0.0% YoY) for Q4 FY26.

Key figure: Net profit ₹11.6 Cr · +0.0% YoY

Open full results → Read the filing ↗